IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $374,000 | +19.5% | 8,460 | 0.0% | 1.23% | +60.4% |
| Q2 2022 | $313,000 | 0.0% | 8,460 | 0.0% | 0.77% | +42.0% |
| Q1 2022 | $313,000 | +21.8% | 8,460 | 0.0% | 0.54% | +85.6% |
| Q4 2021 | $257,000 | -9.5% | 8,460 | 0.0% | 0.29% | -1.7% |
| Q3 2021 | $284,000 | -15.7% | 8,460 | 0.0% | 0.30% | -22.9% |
| Q2 2021 | $337,000 | +5.6% | 8,460 | +19.4% | 0.38% | -9.4% |
| Q1 2021 | $319,000 | +57.1% | 7,085 | +183.4% | 0.42% | +423.5% |
| Q1 2019 | $203,000 | – | 2,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |